News for Vaccibody AS (VACC.OL)

Published at

Mar 2, 2024 1:36 AM

by gurufocus.com

positive

positive

Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp Transcript

Jul 12, 2021 / 02:00PM GMTMichael Thyring Engsig - Vaccibody AS - CEO So good afternoon and good morning to our guests and listeners from the U.S. I'm Michael E

VACC.OL VACC-ME.OL 1HM.DE

Read more →
Published at

Oct 26, 2023 9:00 PM

by globenewswire.com

mixed

mixed

Neoantigen Cancer Vaccine Market Size is Projected to Reach $1.38 billion by 2030: Straits Research

The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...

ZIOP MDGEF MDG1.DE GNCA CVACN.MX CVAC ADXS 688315.SS 5CV.DE 4594.T 0QGJ.L VACC.OL VACC-ME.OL PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRNA.MX MRNA MRKD.BA MRK.SN MRK.PA MRK.MX MRK M1RN34.SA LLY.MX LLY.DE LLY.BA LLY LILY34.SA BNTXN.MX BNTX AGEN 6MK.DE 0Q1G.L 0A45.L 0A3M.L OSE.PA GRTS 0RAD.L

Read more →
Published at

Nov 21, 2022 4:30 PM

by prnewswire.com

mixed

mixed

Genital Herpes Market to Exhibit Growth at a CAGR of 3.2% by 2032 | DelveInsight

/PRNewswire/ -- DelveInsight's Genital Herpes Market Insights report includes a comprehensive understanding of current treatment practices, genital herpes...

GILDD.BA VACC.OL VACC-ME.OL

Read more →
Published at

Aug 17, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Global Human Papillomavirus Associated Cancer Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight

Human Papillomavirus Associated Cancer Pipeline constitutes 50+ key companies continuously working towards developing 50+ Human Papillomavirus Associated...

VIRX VACC.OL VACC-ME.OL THTX TH.TO NEXI IOVA GILDD.BA 0JDK.L 095700.KQ RUBY 299660.KQ

Read more →
Published at

Apr 15, 2022 8:30 AM

by seekingalpha.com

mixed

mixed

Adaptive Biotechnologies: Good Buy For Long-Term Investors (ADPT)

Adaptive Biotechnologies sports a market-leading advantage with its one-of-a-kind proprietary tech. Read why I rate the ADPT stock a Buy for long-term investors.

VACC.OL VACC-ME.OL ADPT 1HM.DE JNJ DJNJ3.BA DJNJ2.BA

Read more →
Published at

Nov 4, 2021 1:00 AM

by globenewswire.com

mixed

mixed

Cervical Cancer Pipeline Offers Promising New Options for Treatment | DelveInsight

The current chemotherapy-dominated landscape of cervical cancer treatment is set to change to include multiple different drug classes. ...

299660.KQ MGNX IOVA GNMSF GMABN.MX GMAB EXEL ADXS 0JDK.L XNCR VACC.OL VACC-ME.OL SGEN RUBY REGN FATE AZN 9926.HK 0A8R.L 095700.KQ

Read more →
Published at

Sep 22, 2021 7:30 PM

by prnewswire.com

negative

negative

HPV 16+ Cancer Market Size Growth to Shore Up at a Substantial CAGR of 21.6% during the Study Period 2018-30 in the 7MM | DelveInsight

/PRNewswire/ -- DelveInsight's HPV 16+ Cancer Market report offers comprehensive coverage of the current treatment practices, pipeline drugs, HPV 16+ Cancer...

VACC.OL VACC-ME.OL

Read more →
Published at

Jul 30, 2021 10:00 PM

by markets.businessinsider.com

negative

negative

Global Neoantigen Cancer Vaccine (Synthetic Long Peptide, Nucleic Acid, Dendritic Cell, Tumor Cell) Market Report 2021

DUBLIN, July 30, 2021 /PRNewswire/ -- The 'Global Neoantigen Cancer Vaccine Market, By Product, By Neoantigen Type, By Route of Administration, By...

ZIOP VACC.OL VACC-ME.OL PFED.BA PFECL.SN PFE.MX PFE.DE PFE OSE.PA MRNA.MX MRNA MRKD.BA MRK.SN MRK.PA MRK.MX MRK MDGEF MDG1.DE M1RN34.SA LLY.MX LLY.DE LLY.BA LLY LILY34.SA GRTS GNCA BNTXN.MX BNTX AGEN ADXS 6MK.DE 688315.SS 4594.T 0RAD.L 0QGJ.L 0Q1G.L 0A45.L 0A3M.L

Read more →